The effect of long-term hormonal treatment on voiding patterns during filling cystometry and on urethral histology in a postpartum, ovariectomized female rat
- PMID: 20201831
- PMCID: PMC2912975
- DOI: 10.1111/j.1464-410X.2010.09268.x
The effect of long-term hormonal treatment on voiding patterns during filling cystometry and on urethral histology in a postpartum, ovariectomized female rat
Abstract
Objective: To study whether long-term treatment with oestrogen (E(2) ), selective E(2) receptor modulators (SERMs), or growth hormone (GH) can prevent the development of abnormal voiding patterns during filling cystometry (CMG) in a postpartum, ovariectomized (Ovx) female rat.
Materials and methods: Immediately after spontaneous delivery, 60 primiparous Sprague-Dawley rats were randomly divided into six equal groups. One group served as uninjured sham controls and five groups underwent intravaginal balloon dilatation. On day seven, previously dilated rats underwent bilateral Ovx and implantation of a subcutaneous hormone-delivery pump. The five treatment groups received normal saline (control), E(2) , raloxifene, levormeloxifene, or GH for 7 weeks. Conscious CMG was performed 7 weeks after Ovx. Urethral sphincter tissue was harvested for elastin immunohistochemistry and real-time polymerase chain reaction of α(1A) -adrenoceptor mRNA.
Results: No abnormal voiding patterns were detected in the group treated with GH. The E(2) , raloxifene and levormeloxifene groups had greater detrusor overactivity and urethral relaxation incontinence than control rats. The raloxifene group had a significantly lower baseline bladder pressure and opening pressure. GH-treated rats had higher elastin content in the urethra. Urethral α(1A) -adrenoceptor mRNA concentration was significantly lower in the SERM-treated rats compared with controls.
Conclusions: GH prevents the development of abnormal voiding patterns during filling CMG in a rat model of parturition-induced incontinence; E(2) and SERMs may worsen voiding patterns.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.
Figures








Similar articles
-
The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats.BJU Int. 2008 Jul;102(2):242-6. doi: 10.1111/j.1464-410X.2008.07582.x. Epub 2008 Jul 1. BJU Int. 2008. PMID: 18336614 Free PMC article.
-
Activation of VEGF and ERK1/2 and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model.Urology. 2012 Oct;80(4):953.e1-8. doi: 10.1016/j.urology.2012.05.030. Epub 2012 Aug 28. Urology. 2012. PMID: 22950999
-
Effect of extended-term estrogen on voiding in a postpartum ovariectomized rat model.Can Urol Assoc J. 2007 Sep;1(3):256-63. doi: 10.5489/cuaj.79. Can Urol Assoc J. 2007. PMID: 18542800 Free PMC article.
-
Urodynamic effects of estradiol (E2) in ovariectomized (ovx) rats.Endocrine. 2004 Feb;23(1):25-32. doi: 10.1385/ENDO:23:1:25. Endocrine. 2004. PMID: 15034193
-
[Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].Prog Urol. 2007 Nov;17(6 Suppl 2):1264-84. Prog Urol. 2007. PMID: 18214138 Review. French.
Cited by
-
Delayed Treatment With Low-intensity Extracorporeal Shock Wave Therapy in an Irreversible Rat Model of Stress Urinary Incontinence.Urology. 2020 Jul;141:187.e1-187.e7. doi: 10.1016/j.urology.2020.03.035. Epub 2020 Apr 10. Urology. 2020. PMID: 32283169 Free PMC article.
-
Effects of birth trauma and estrogen on urethral elastic fibers and elastin expression.Urology. 2010 Oct;76(4):1018.e8-13. doi: 10.1016/j.urology.2010.02.055. Epub 2010 May 15. Urology. 2010. PMID: 20472273 Free PMC article.
-
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.Menopause. 2015 Jul;22(7):786-96. doi: 10.1097/GME.0000000000000365. Menopause. 2015. PMID: 25423325 Free PMC article. Review.
-
Effects of prolonged vaginal distension and β-aminopropionitrile on urinary continence and urethral structure.Urology. 2011 Oct;78(4):968.e13-9. doi: 10.1016/j.urology.2011.07.1381. Urology. 2011. PMID: 21982017 Free PMC article.
-
Age-Related Changes in Urethral Structure and Responds to Injury: Single-Cell Atlas of a Rat Model of Vaginal Birth Injury induced Stress Urinary Incontinence.Res Sq [Preprint]. 2024 Feb 12:rs.3.rs-3901406. doi: 10.21203/rs.3.rs-3901406/v1. Res Sq. 2024. PMID: 38410468 Free PMC article. Preprint.
References
-
- Huang AJ, Brown JS, Kanaya AM, et al. Quality-of-life impact and treatment of urinary incontinence in ethnically diverse older women. Arch Intern Med. 2006 Oct 9;166:2000–6. - PubMed
-
- Andersson KE. Drug therapy for urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 Apr;14:291–313. - PubMed
-
- Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol. 1999 Jul;94:66–70. - PubMed
-
- Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. Jama. 2005 Feb 23;293:935–48. - PubMed
-
- Goldstein SR, Nanavati N. Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol. 2002 Sep;187:521–7. - PubMed